2,4-Dibromo-6-methylpyrimidine

Catalog No.: 
ACMSUR827
CAS No.: 
2054922-16-4
Molecular Formula: 
C5H4Br2N2
Molecular Weight: 
251.91
2,4-Dibromo-6-methylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$54.00In stockInquiry
1g95%$136.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4-Dibromo-6-methylpyrimidine
IUPAC Name2,4-dibromo-6-methylpyrimidine
Molecular FormulaC5H4Br2N2
Molecular Weight251.91
SMILESCC1=CC(Br)=NC(Br)=N1
InChI KeyLWUKSBFPJGXVEH-UHFFFAOYSA-N
SynonymPyrimidine, 2,4-dibromo-6-methyl-;2,4-Dibromo-6-methylpyrimidine;2, 4 -dibromo-1-6-Methylpyrimidine
CAS No.2054922-16-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMSUR827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMSUR827 route compound structure diagram
    ACMSUR8272054922-16-4In Stock
  4. Then
  5. ACMSUR827 route product structure diagram
    ACMSUR8272054922-16-4In Stock
Inquiry

2. ACMSUR827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOLKB102 route compound structure diagram
    ACOLKB1021416305-91-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMSUR827 route product structure diagram
    ACMSUR8272054922-16-4In Stock
Inquiry

3. ACMSUR827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOLKB102 route compound structure diagram
    ACOLKB1021416305-91-3In Stock
  4. Then
  5. ACMSUR827 route product structure diagram
    ACMSUR8272054922-16-4In Stock
Inquiry

Comments (0)